Trippbio Announces Agreement With NIAID To Evaluate Pancytovir Analogs For The Treatment Of Viral Diseases

  • Ralph Tripp
Period13 Sep 2022

Media coverage

3

Media coverage

  • TitleTrippbio Announces Agreement With NIAID To Evaluate Pancytovir Analogs For The Treatment Of Viral Diseases
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/09/22
    PersonsRalph Tripp
  • TitleTrippBio Announces Agreement with NIAID to Evaluate PanCytoVir™ Analogs for the Treatment of Viral Diseases
    Media name/outletEIN Presswire
    Country/TerritoryUnited States
    Date13/09/22
    PersonsRalph Tripp
  • TitleTrippbio Announces Agreement With NIAID To Evaluate Pancytovir Analogs For The Treatment Of Viral Diseases
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/09/22
    PersonsRalph Tripp